QBR A/S

QuantBioRes is a Copenhagen-based biotechnology company applying computational quantum biology and molecular simulation to AMR drug discovery. Its platform uses physics-based modelling to understand resistance mechanisms at the atomic level , identifying novel drug targets and designing compounds that are less susceptible to known resistance mutations, offering a computationally driven approach to accelerating the discovery of resilient new antibiotics.